Comparative evaluation of SARS-CoV-2 antigens as capture and detection elements in an in-house antigen-based ELISA for COVID-19 total antibody detection
The RBD-based EIA provides a reliable, efficient platform for COVID-19 serological surveillance, suitable for both human and animal testing, and supports broader applications in vaccine evaluation and One Health monitoring.
Authors
- Fedelino F. Malbas
- Catalino S. Demetria
- Normando C. Gonzaga
- maria sarah L. Lenon
- Catherine B. Masangkay
- Prince Andre Diagmel
- Gloria June D. Quiñones
- Erryl Kate Noveno
- Jhunel G. Vinarao
- Mary Glazel Noroña
- Faustino C. Icatlo
- Leah Babad
Institutions
- Research Institute for Tropical Medicine (PH)
Publication Details
- Journal
- International Journal of Infectious Diseases
- Published
- 2026-02-04
- DOI
- https://doi.org/10.1016/j.ijid.2026.108461
- Primary Topic
- SARS-CoV-2 detection and testing
- Type
- article
- Field-Weighted Citation Impact
- 0.00